share_log

Replimune Group Inc. Expects Enrollment Of First Patients In Phase 3 Confirmatory Trial Of RP1 In Advanced Melanoma In 2H 2024

Replimune Group Inc. Expects Enrollment Of First Patients In Phase 3 Confirmatory Trial Of RP1 In Advanced Melanoma In 2H 2024

Replimune Group Inc. 预计将在2024年下半年入组首批患者参加晚期黑色素瘤RP1的3期确认性试验
Benzinga ·  05/16 20:11

Replimune Group Inc. Expects Enrollment Of First Patients In Phase 3 Confirmatory Trial Of RP1 In Advanced Melanoma In 2H 2024

Replimune Group Inc. 预计将在2024年下半年入组首批患者参加晚期黑色素瘤RP1的3期确认性试验

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发